Skip to evidence report

ASPC.activated: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 4,466 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for ASPC.activated
#Trait / studyIndividual trait IDMean IC score
1Hallux valgus (acquired)FING0000060166.33
2Inguinal hernia | digestiveUKBB0000036255.87
3Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary OperationsUKBB0000058754.38
4Inguinal hernia | HerniaUKBB0000036353.32
5Hip indexGCST01222953.01
6Waist-hip indexGCST9002002752.11
7Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST9047625851.96
8Waist-to-hip ratio adjusted for BMIGCST9002002551.72
9A body shape indexGCST9002002451.48
10Hip indexGCST9002002646.41
11Abdominal hernia | digestiveUKBB0000000245.46
12Inguinal herniaFING0000068145.42
13T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42)GCST9032060544.66
14Waist circumference adjusted for body mass indexGCST9002002943.80
15HerniaFING0000061642.58
16CBLN4 levelsGCST9046855441.66
17Carpal tunnel syndromeFING0000025741.28
18Hip width to body height ratioGCST9027026040.54
19TNC/VCAM1 ratioGCST9031592740.45
20Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressureUKBB0000037639.79
21CLMP/PIK3IP1 ratioGCST9031413439.13
22COL6A3/CST3 ratioGCST9031417438.65
23Ribothymidine levels in chronic kidney diseaseGCST9025755438.21
24Intraocular pressure (confirmatory factor analysis Factor 26)GCST9030936038.10
25DLK1/FAP ratioGCST9031449137.85
26Waist-to-Hip ratio | Body measurementUKBB0000090537.48
27QC T1 inverse SNRGCST9000634837.03
28BOC levelsGCST9046845836.90
29Prescriptions - latanoprost | prostaglandin analogUKBB0000068636.78
30Abdominal hernia (PheCode 550)GCST9047605936.75
31ROBO2/SCARF2 ratioGCST9031578436.57
32Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heelUKBB0000032136.41
33Oblique pelvic inlet lengthGCST9044890936.18
34Pulse pressureGCST9030170335.73
35Heel bone mineral density (BMD) (left) | Bone-densitometry of heelUKBB0000031335.01
36Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressureUKBB0000037734.94
37Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heelUKBB0000032234.50
38Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heelUKBB0000031634.49
39Waist-hip indexGCST01222834.42
40Dupuytren's diseaseGCST9030125234.32
41HSPG2/IGFBP6 ratioGCST9031509134.27
42Operation code - inguinal/femoral hernia repair | OperationsUKBB0000056134.08
43Bone density (confirmatory factor analysis Factor 19)GCST9030935333.86
44Waist-to-hip ratio adjusted for BMIGCST01223033.58
45Ventral hernia (PheCode 550.5)GCST9047606333.49
46ROBO2 levelsGCST9047049033.33
47COL4A1 levelsGCST9046881832.05
48Osteoporosis NOS (PheCode 743.11)GCST9047626032.03
49Open-angle glaucoma (PheCode 365.1)GCST9047587232.01
50Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heelUKBB0000032331.91
51Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heelUKBB0000031731.91
52Autorefraction - 6mm asymmetry index (right) | EyesightUKBB0000007431.43
53EGFR/FAP ratioGCST9031461331.37
54Waist circumference adjusted for body mass indexGCST9030289231.36
55Pulse pressureGCST9047278531.00
56Haemorrhoids and perianal venous thrombosisFING0000059930.93
57Heel broadband ultrasound attenuation (left) | Bone-densitometry of heelUKBB0000031930.90
58COL6A3/COLEC12 ratioGCST9031417330.80
59Dermatochalasis (PheCode 374.6)GCST9047589430.79
60Pelvic organ prolapseGCST9010247030.77
61Primary open-angle glaucoma, strictFING0000121430.51
62Osteoporosis (PheCode 743.1)GCST9047625930.28
63Heel bone mineral density (BMD) (right) | Bone-densitometry of heelUKBB0000031430.08
64Descending aorta diameterGCST9026739130.02
65IGFBP6/SMOC2 ratioGCST9031513829.95
66Inguinal hernia (PheCode 550.1)GCST9047606029.88
67Impedance of arm right (UKB data field 23109)GCST9046817229.45
68Umbilical hernia | digestiveUKBB0000088029.34
69Umbilical hernia | HerniaUKBB0000088129.20
70Corneal resistance factorGCST9010056829.13
71Autorefraction - 6mm strong meridian (left) | EyesightUKBB0000007528.99
72Autorefraction - 6mm weak meridian (left) | EyesightUKBB0000007928.61
73Hallux valgus (Bunion) (PheCode 735.3)GCST9047625128.51
74Ankle spacing width | Bone-densitometry of heelUKBB0000003528.45
75Takes medication for Macular Degeneration?GCST9047538728.25
76Fracture of forearmGCST9028127328.24
77Impedance of arm left (UKB data field 23110)GCST9046817128.06
78Subclinical hyperthyroidism in pregnancyGCST9043519927.60
79Pulse pressureGCST9030170127.21
80Macular degenerationGCST9047538626.90
81Gout (PheCode 274.1)GCST9004366226.69
82Prescriptions - prostaglandin analogUKBB0000069726.29
83GlaucomaGCST9047586926.27
84Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heelUKBB0000032426.25
85Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heelUKBB0000031826.25
86Waist-to-hip ratio adjusted for BMIGCST9002599626.24
87Heel bone mineral density (BMD) | Bone-densitometry of heelUKBB0000031526.20
88VNN2 levelsGCST9061851025.48
89Corneal hysteresis (left) | Intraocular pressureUKBB0000014825.39
90Other mental disorders due to brain damage and dysfunction and to physical diseaseFING0000107225.22
91Impedance of arm (right) | Impedance measuresUKBB0000035725.14
92ZNRF4 levelsGCST9047110425.14
93IDP dMRI ProbtrackX L3 unc lGCST9000432525.06
94Corneal resistance factor (left) | Intraocular pressureUKBB0000015024.75
95RET levelsGCST9047045824.68
96Free testosterone levelsGCST9023982624.63
97TNC levelsGCST9047089524.43
98Heel broadband ultrasound attenuation (right) | Bone-densitometry of heelUKBB0000032024.42
99PTPRH levelsGCST9047038224.22
100COL6A3/SMOC2 ratioGCST9031417824.20
101IDP dMRI ProbtrackX MO str rGCST9000402424.16
102Heel bone mineral densityGCST00628824.05
103aparc-DKTatlas rh area inferiorparietalGCST9000327123.91
104Peritonsillar abscessFING0000116023.88
105Corneal hysteresis (right) | Intraocular pressureUKBB0000014923.45
106VCAN levelsGCST9047103223.44
107Corneal resistance factorGCST9030868223.42
108Impedance of arm (left) | Impedance measuresUKBB0000035623.15
109IDP T1 FAST ROIs V cerebellum VIIIaGCST9000257923.10
110FAP levelsGCST9046918923.05
111Central corneal thicknessGCST00636622.82
112Coronary artery calcificationGCST9050307422.81
113ENG levelsGCST9046910822.75
114SCARA5 levelsGCST9047053322.65
115HEG1 levelsGCST9046944422.50
116BA-exvivo lh area entorhinalGCST9000322022.50
117IDP T1 FAST ROIs R occ poleGCST9000254622.50
118Autorefraction - 6mm asymmetry index (left) | EyesightUKBB0000007322.25
119C7 levelsGCST9042233222.21
120Pulse pressure, automated reading | Cardiovascular measurementUKBB0000071422.04
121Coronary artery calcificationGCST9027845622.02
122Pulse pressureGCST9047278321.74
123Autorefraction - 3mm weak meridian (left) | EyesightUKBB0000006921.73
124Hip circumference adjusted for BMIGCST9002002821.68
125BPIFB1/GLRX ratioGCST9031353021.56
126Pulse pressureGCST9030170221.54
127Coronary artery plaque burdenGCST9050307521.49
128Pulse pressure (BMI adjusted)GCST9033516721.45
129Primary open angle glaucoma (PheCode 365.11)GCST9047587521.42
130IDP dMRI ProbtrackX MD unc lGCST9000424421.38
131Pulse pressure, automated reading | Cardiovascular measurementUKBB0000071521.35
132Glaucoma suspectFING0000057921.35
133Fracture of forearmFING0000055421.34
134Phenylalanine levelsGCST9024340721.33
135Corneal resistance factor (right) | Intraocular pressureUKBB0000015121.31
136EGFR levelsGCST9046908521.19
137Lung cancerGCST9001181221.17
138Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB0000042921.14
139Retinal thickness (functional principal component 2)GCST9045572221.09
140Eye conditions (confirmatory factor analysis Factor 25)GCST9030935921.06
141CST3/TFF3 ratioGCST9031429920.92
142Autorefraction - 3mm strong meridian (left) | EyesightUKBB0000006520.88
143Autorefraction - 6mm weak meridian (right) | EyesightUKBB0000008020.79
144Autorefraction - 3mm weak meridian (right) | EyesightUKBB0000007020.72
145HeightGCST9001873920.72
146BA-exvivo lh volume entorhinalGCST9000284820.67
147IDP dMRI TBSS L1 External capsule LGCST9000410820.58
148Autorefraction - 6mm strong meridian (right) | EyesightUKBB0000007620.49
149Treatment speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB0000083520.44
150Female genital prolapseFING0000053520.42
151MAMDC2 levelsGCST9046984120.32
152Impedance of whole body (UKB data field 23106)GCST9046817320.32
153Glaucoma (multi-trait analysis)GCST00972220.26
154T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST9032087620.24
155Autorefraction - 3mm strong meridian (right) | EyesightUKBB0000006620.15
156Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB0000071820.01
157Appendicular lean massGCST9000002719.98
158Waist circumference adjusted for body mass indexGCST01222619.82
159Pulse pressureGCST9031029619.77
160Macular degeneration, wet (PheCode 362.22)GCST9047585219.55
161Pulse pressure, combined automated + manual reading | Cardiovascular measurementUKBB0000071919.47
162Female genital prolapse | Noninflammatory disorders of female genital tractUKBB0000024419.37
163DTI autoptx MD unc l tractGCST9038524519.33
164Subpubic angleGCST9044890819.07
165Kyphosis (MTAG)GCST9057004719.02
166Free androgen indexGCST9023982418.85
167Progressive vascular leukoencephalopathyFING0000121818.74
168KeloidGCST9065248818.59
169GSTA4 levelsGCST9024128318.39
170aparc-Desikan rh area inferiorparietalGCST9000311418.31
171Retinal breaks without detachmentFING0000125818.31
172CTSD/PRCP ratioGCST9031431218.26
173ERBB3 levelsGCST9046914018.26
174CD200R1 levelsGCST9046860518.24
175Femur length to body height ratioGCST9027025618.11
176Forced expiratory volume in 1-second (FEV1), predicted | SpirometryUKBB0000025218.10
177T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57)GCST9032062018.04
178BCAN/DPP6 ratioGCST9031347817.95
179A body shape indexGCST01223117.89
180PSPN levelsGCST9047036417.77
181Barrett's esophagus (PheCode 530.13)GCST9047604817.61
182Medication use (antithrombotic agents)GCST9001876217.59
183Lung function (FVC)GCST00742917.52
184Impedance of leg (left) | Impedance measuresUKBB0000035817.48
185CDON/SCARA5 ratioGCST9031399517.47
186Angina pectorisGCST9001857317.46
187Calcific aortic valve stenosisGCST9031029317.45
188IDP dMRI TBSS L2 Sagittal stratum LGCST9000415417.40
189ICAM2 levelsGCST9046949917.33
190Pelvic inlet widthGCST9044891017.30
191COL6A3/OGN ratioGCST9031417717.20
192HSPG2/SMOC2 ratioGCST9031509317.17
193FOLH1 levelsGCST9042719217.14
194Intraocular pressureGCST00407417.11
195Glaucoma (primary open-angle)GCST9039972517.10
196Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5ECGU00000517.09
197Impedance of leg (right) | Impedance measuresUKBB0000035917.06
198Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB0000071617.02
199IDP dMRI ProbtrackX L3 unc rGCST9000432617.00
200Iliac isthmus breadthGCST9044890716.99
201SRPX levelsGCST9047074416.94
202Prolapse of vaginal walls | genitourinaryUKBB0000071216.93
203Impedance of whole body | Impedance measuresUKBB0000036016.90
204LGALS3 levelsGCST9046976116.86
205TNXB levelsGCST9047093016.86
206IDP dMRI TBSS L1 FornixGCST9000408016.84
207IDP dMRI ProbtrackX FA ilf lGCST9000393916.81
208Nerve, nerve root and plexus disordersFING0000086216.79
209CNTN1 levelsGCST9046880316.77
210DTI autoptx FA str r tractGCST9038513616.77
211PILRA/TNFRSF1A ratioGCST9031565516.74
212Diaphragmatic herniaFING0000041916.65
213Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06)GCST9029158216.61
214Depression/anxiety (weighted GWA)GCST9026727716.60
215Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurementUKBB0000071716.59
216FCRL2/TNFRSF13B ratioGCST9031480116.55
217T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126)GCST9032068916.49
218Genital prolapse | genitourinaryUKBB0000028216.44
219Pulse pressure (BMI unadjusted)GCST9033516616.40
220CCN3/FAP ratioGCST9031372116.38
221T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24)GCST9032058716.37
222Alzheimer's disease (MTAG)GCST9044905516.36
223T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127)GCST9032069016.34
224ACVRL1/TNFRSF19 ratioGCST9031315916.30
225HeightGCST9027863716.27
226Olsenella C abundance in stoolGCST9003249316.24
227Volume of right accessory basal nucleusGCST9047500616.24
228Intra-ocular pressure, corneal-compensated (right) | Intraocular pressureUKBB0000037516.20
229COL6A3/TAFA5 ratioGCST9031418016.17
230T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123)GCST9032068616.14
231Volume of right cortico-amygdaloid transition areaGCST9047501816.08
232Hereditary deficiency of other clotting factorsFING0000061216.04
233CASP1 levelsGCST9046854316.03
234Use of antiglaucoma preparations and mioticsFING0000140915.98
235Appendicular lean massGCST9000002515.97
236Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB0000072015.92
237Takes medication for heart attack?GCST9047521215.92
238ST6GALNAC2 levelsGCST9024025115.91
239VWF levelsGCST9047106515.89
240Nonrheumatic aortic valve disorders (PheCode 395.2)GCST9047591415.89
241IDP dMRI ProbtrackX L2 unc lGCST9000429815.88
242Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivityGCST9030282015.86
243Haemorrhoidal diseaseGCST9001403315.75
244FUT8/TNFSF14 ratioGCST9031489515.70
245PSME2/RBKS ratioGCST9031573715.68
246RFC4 levelsGCST9047046015.51
247MATN2 levelsGCST9046986415.49
248aparc-DKTatlas rh volume parstriangularisGCST9000291115.48
249Appendicular lean massGCST9000002615.46
250ScoliosisFING0000128115.46
251Tibia length to body height ratioGCST9027025815.45
252T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST9032088715.40
253Hand grip strength right (UKB data field 47)GCST9046816915.36
254T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40)GCST9032085915.35
255T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45)GCST9032060815.34
256Diaphragmatic hernia (PheCode 550.2)GCST9047606115.34
257GlaucomaGCST9047538315.17
258Hand grip strength (right) | Hand grip strengthUKBB0000030115.13
259Macular degeneration (senile) of retina NOS (PheCode 362.29)GCST9047585715.10
260Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurementUKBB0000072115.10
261Operation code - inguinal hernia repair | OperationsUKBB0000056014.99
262EFEMP1/TGFBR3 ratioGCST9031459714.98
263CD300LG/DSG2 ratioGCST9031380214.89
264aparc-pial rh area inferiorparietalGCST9000318114.78
265Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3ECGU00000314.77
266Volume of right basal nucleusGCST9047501214.74
267Diverticulosis and diverticulitis (PheCode 562)GCST9047607314.71
268IDP dMRI TBSS MD Cingulum cingulate gyrus LGCST9000406214.69
269COL6A3/HSPG2 ratioGCST9031417514.68
270Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4ECGU00000414.66
271Intra-ocular pressure, corneal-compensated (left) | Intraocular pressureUKBB0000037414.61
272Ankle spacing width (left) | Bone-densitometry of heelUKBB0000003314.59
273IDP dMRI ProbtrackX L2 ilf lGCST9000428714.57
274ENPP7 levelsGCST9046911814.55
275Total protein levelsGCST9002599514.50
276Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6ECGU00000614.49
277Heart failure and coronary heart diseaseFING0000060414.47
278Autorefraction - 3mm strong meridian angle (left) | EyesightUKBB0000006714.45
279SCAMP3/VPS53 ratioGCST9031580714.43
280Sitting height | Body size measuresUKBB0000077114.43
281REST UKBBICA NET100 1287GCST9038714114.43
282Ankle spacing width (right) | Bone-densitometry of heelUKBB0000003414.42
283Hip circumference adjusted for BMIGCST01222714.42
284PKD1 levelsGCST9047024014.40
285DPP6 levelsGCST9046903414.32
286T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90)GCST9032090914.29
287Illnesses of father - Heart disease | Family historyUKBB0000034214.29
288ADAMTS13 levelsGCST9046822214.28
289Takes medication for Glaucoma?GCST9047538414.23
290Valine levelsGCST9024345314.20
291SCARA5/TNC ratioGCST9031581014.10
292Seated height | Body size measuresUKBB0000076314.08
293Intestinal infectious diseasesFING0000068914.03
294T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76)GCST9032089513.90
295Perforation of tympanic membraneFING0000115513.89
296PATE4 levelsGCST9024240513.87
297Incisional hernia (PheCode 550.6)GCST9047606413.84
298T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37)GCST9032085613.83
299T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91)GCST9032065413.82
300CD34 levelsGCST9046862613.75
301T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51)GCST9032061413.71
302IFNGR1/THBD ratioGCST9031513013.68
303CDH5/ENG ratioGCST9031395413.66
304SLITRK6 levelsGCST9047067113.63
305Diverticulosis (PheCode 562.1)GCST9047607613.61
306T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82)GCST9032064513.61
307T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77)GCST9032089613.59
308Pulse pressureGCST9047278413.54
309CR2/TNFRSF13B ratioGCST9031422513.54
310Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasoundUKBB0000044613.49
311LAMB1 levelsGCST9046973213.46
312Umbilical hernia (PheCode 550.4)GCST9047606213.46
313Glaucoma (primary open-angle)GCST9001176813.41
314DNAJA2/PLXNA4 ratioGCST9031450413.39
315Cerebrospinal fluid 3-hydroxyhexanoate levelsGCST9031810813.38
316Carotid intima-media thickness (MTAG)GCST9044906113.38
317Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2ECGU00000213.36
318aparc-a2009s lh area S-collat-transv-antGCST9000334613.32
319T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60)GCST9032062313.32
320Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB0000047713.32
321Height (maximum, inv-normal transformed)GCST9047535913.29
322Bone density T-scoreGCST9027862013.28
323OLR1 levelsGCST9001202013.20
324height (mean, inv-normal transformed)GCST9047536213.19
325CXCL10/WARS ratioGCST9031433213.17
326aparc-a2009s lh volume S-centralGCST9000296913.13
327Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8ECGU00000813.11
328IDP dMRI TBSS L1 External capsule RGCST9000410713.11
329SERPING1 levelsGCST9047060013.11
330Age-related eyesight deterioration (confirmatory factor analysis Factor 27)GCST9030936113.10
331Hand grip strength left (UKB data field 46)GCST9046816813.07
332Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivityGCST9030277913.00
333Nonalcoholic fatty liver diseaseGCST9005478212.97
334aseg global volume WM-hypointensitiesGCST9000260412.96
335DTI autoptx L2 unc l tractGCST9038519112.82
336height (minimum, inv-normal transformed)GCST9047536512.81
337TNFRSF14/TNFSF14 ratioGCST9031593612.81
338PTPRF/PTPRS ratioGCST9031575112.81
339ADGRB3 levelsGCST9046823412.79
340Stable angina pectorisGCST9001869512.75
341DTI TBSS L3 Retrolenticular part of internal capsule LGCST9038454512.71
342Acquired foot deformities (PheCode 735)GCST9047624712.70
343T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59)GCST9032087812.69
344CTSO/IGF2R ratioGCST9031431712.66
345AIFM1/EGF ratioGCST9031321912.64
346Standing height | Body size measuresUKBB0000079612.63
347CDH5 levelsGCST9046867612.60
348LTBP2 levelsGCST9046981412.59
349Other specified and unspecified disorders of lensFING0000110112.59
350diastolic blood pressure (DBP, mean, inv-normal transformed)GCST9047525512.56
351QC T1-to-standard nonlinear alignment discrepancyGCST9000634612.55
352KDR/VWF ratioGCST9031524512.52
353ESR1 levelsGCST9046915512.50
354EndometriosisGCST9001861912.50
355IDP dMRI ProbtrackX MD unc rGCST9000424512.49
356PLXDC1 levelsGCST9047026312.49
357Calcific aortic valvular stenosis, operatedFING0000023412.48
358T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115)GCST9032067812.46
359NOTCH3/PTPRS ratioGCST9031554712.36
360Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary OperationsUKBB0000058312.33
361DTI TBSS MD Retrolenticular part of internal capsule LGCST9038459312.32
362T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26)GCST9032084512.30
363HGF/TNFSF14 ratioGCST9031506012.29
364SCARF2 levelsGCST9047053712.29
365Benign mammary dysplasiaFING0000015112.26
366Maximum indexed left atrial volumeGCST9001901212.26
367FGR levelsGCST9046923612.26
368rfMRI connectivity (ICA100 edge 399)GCST9000525212.23
369AOC3 levelsGCST9046832212.21
370SFRP2 levelsGCST9024272712.21
371Pelvic widthGCST9044891112.21
372Benign neoplasm: Colon, unspecifiedFING0000017212.19
373ADGRD1 levelsGCST9046823512.18
374LEPR/NTRK2 ratioGCST9031531312.15
375SSC5D levelsGCST9047074812.14
376Bone density Z-scoreGCST9027862112.11
377FracturesGCST00698012.11
378GlaucomaFING0000057712.04
379ThalamNuclei rh volume CeMGCST9000275112.02
380T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11)GCST9032057412.01
3811-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levelsGCST9020069211.98
382Ventral herniaFING0000142811.97
383CDON levelsGCST9046868711.96
384Liver proton density fat fractionGCST9026735211.95
385GGH/INHBC ratioGCST9031492811.92
386T1 FreeSurfer DKT rh fusiform thicknessGCST9038432211.92
387HYOU1/THBD ratioGCST9031510611.91
388Descending aorta strainGCST9026738911.90
389Fibroblastic disorders | Other soft tissue disordersUKBB0000024611.88
390QC rfMRI-to-T1 linear alignment discrepancyGCST9000635311.85
391NRP1 levelsGCST9047008511.85
392CHI3L1/HSPG2 ratioGCST9031404311.84
393aparc-DKTatlas rh area cuneusGCST9000326811.80
394MSMB levelsGCST9046994911.79
395F3 levelsGCST9046917011.79
396Varicose veins (PheCode 454)GCST9047601211.78
397TGFBR3 levelsGCST9047084811.77
398Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9ECGU00000911.76
399APOM/MCAM ratioGCST9031331511.76
400Coronary angioplastyFING0000035711.67
401Phospholipids to total lipids in large VLDL percentage (UKB data field 23589)GCST9026968611.66
402PSG1 levelsGCST9047035311.61
403Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457)GCST9026955411.59
404CD79B/FCRL2 ratioGCST9031390011.58
405Heart attackGCST9047521111.57
406ICD10 N81: Female genital prolapseGCST9045421411.57
407Diacylglycerol_38:5_[M+H-H2O]1+ levelsGCST9006020011.53
408HeightGCST9030289011.53
409L1CAM levelsGCST9046972311.53
410Left ventricular wall thickness (maximal)GCST9043526311.50
411Fracture of rib(s), sternum and thoracic spineFING0000055811.49
412Physical activity (Total log acceleration 8am-10am)GCST9006141311.47
413Aortic aneurysmFING0000010211.45
414Disorders of choroid and retinaFING0000043811.44
415Blood cell traits latent factor 21 (red cell)GCST9055926311.43
416Mean volume of bilateral amygdalaGCST9047499411.39
417aparc-DKTatlas lh volume cuneusGCST9000286511.39
418IDP dMRI TBSS MD FornixGCST9000403211.39
419IDP dMRI TBSS MD Pontine crossing tractGCST9000402811.38
420Fractured/broken bones in last 5 years | Medical conditionsUKBB0000025811.37
421Forced vital capacity FVC Z score (UKB data field 20257)GCST9046816711.36
422CST6/NECTIN4 ratioGCST9031430311.36
423IDP dMRI TBSS L3 FornixGCST9000417611.36
424Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7ECGU00000711.35
425What is your height? (cm, inv-normal transformed)GCST9047536811.34
426IDP dMRI ProbtrackX L3 ifo rGCST9000431311.34
427Volume of left paralaminar nucleusGCST9047498211.31
428Operation code - varicose vein surgery | OperationsUKBB0000056811.30
429COMP/DPP4 ratioGCST9031418811.30
430ADAMTS8 levelsGCST9046822711.28
431Volume of right whole amygdalaGCST9047505411.27
432CCDC80/CCL27 ratioGCST9031366911.27
433Serine levelsGCST9020041511.27
434T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39)GCST9032085811.26
435Forearm length to body height ratioGCST9027025711.26
436IGF1 levelsGCST9002598911.24
437Main speciality of consultant (recoded) - Ophthalmology | Summary AdministrationUKBB0000041911.23
438Height, inverse-rank normalizedFING0000060711.23
439Glaucoma (primary open-angle)GCST9001176611.22
440Autorefraction - 6mm strong meridian angle (right) | EyesightUKBB0000007811.20
441Abscess of anal and rectal regionsFING0000000511.20
442IDP dMRI TBSS MD External capsule LGCST9000406011.19
443EIF4G1/TBC1D23 ratioGCST9031463911.18
444POSTN levelsGCST9047028811.18
445Body fat percentage (adjusted for testosterone and SHBG)GCST9043217911.17
446Other predominantly sexually transmitted diseases, not elsewhere classifiedFING0000108911.16
447Umbilical herniaFING0000139511.15
448Anterior thigh muscle fat infiltration percentageGCST9026735111.13
449APOF levelsGCST9046833911.12
450aseg global volume-ratio BrainSegVol-to-eTIVGCST9000261211.12
451X-17676 levelsGCST9020054811.11
452aparc-a2009s rh volume S-centralGCST9000304311.10
453Tonsillectomy and adenotomyFING0000136711.08
454T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52)GCST9032087111.08
455LTBR levelsGCST9024317611.01
456LILRB4 levelsGCST9042670811.01
457IFIT2 levelsGCST9009086411.00
458Volume of right basal nucleusGCST9047491010.99
459NOTCH1 levelsGCST9047006510.96
460Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivityGCST9030276010.96
461Disorders of muscle, ligament, and fascia | musculoskeletalUKBB0000018710.94
462Hand grip strength (baseline)GCST9056584510.94
463Other aneurysm (PheCode 442)GCST9047599210.93
464Operation code - haemorroidectomy / piles surgery/ banding of piles | OperationsUKBB0000055710.92
465FST levelsGCST9046927310.89
466Diverticular disease of intestine | Other diseases of intestinesUKBB0000018910.87
467Contracture of palmar fascia [Dupuytren's disease] | musculoskeletalUKBB0000014610.86
468COMP/MYOC ratioGCST9031419110.81
469C1QL2 levelsGCST9046848710.81
470Hernia of abdominal wallFING0000061710.81
471Coronary atherosclerosis (PheCode 411.4)GCST9004395710.78
472IDP dMRI TBSS OD FornixGCST9000440710.76
473Operation code - carpal tunnel surgery | OperationsUKBB0000055310.74
474IDP dMRI TBSS MD Superior fronto-occipital fasciculus RGCST9000406910.73
475CLU levelsGCST9046879310.73
476HHIP levelsGCST9061709710.72
477COLEC12/TGFBR2 ratioGCST9031418610.71
478Other hammer toe(s) (acquired)FING0000105410.69
479SIL1 levelsGCST9047063810.68
480aparc-DKTatlas lh area entorhinalGCST9000323810.66
481DPP4/ITGB1 ratioGCST9031454010.65
482PLXDC2 levelsGCST9047026410.64
483RND3 levelsGCST9061806610.63
484Macular degeneration, dry (PheCode 362.21)GCST9047585110.60
485NCR3LG1 levelsGCST9047001010.59
486Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARBUKBB0000069010.58
487N-acetyl-2-aminoadipate levelsGCST9020026810.53
488Drusen (degenerative) of retina (PheCode 362.27)GCST9047585510.51
489Anterior thigh muscle volumeGCST9026734910.51
490CD300LG levelsGCST9046862310.51
491Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1ECGU00000110.49
492PolyarthrosisFING0000118110.48
493Low hand grip strength (60 years and older) (EWGSOP)GCST9000752610.48
494aparc-a2009s rh volume G-front-inf-TriangulGCST9000301210.47
495T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST9032060410.47
496CX3CL1 levelsGCST9027477810.45
497Phospholipids in large HDL (UKB data field 23560)GCST9026965710.43
498HRC levelsGCST9046947510.42
499RBP7 levelsGCST9047044010.41
500APP/FKBP1B ratioGCST9031332310.34
501IDP dMRI ProbtrackX L3 ilf lGCST9000431410.33
502Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB0000044510.32
503aparc-Desikan lh thickness cuneusGCST9000344910.31
504Degeneration of macula and posterior pole of retina (PheCode 362.2)GCST9047584910.26
505Standing height (UKB data field 50)GCST9046817810.25
506T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54)GCST9032087310.24
507Triglyceride to HDL cholesterol ratioGCST9029595110.23
508Coronary artery / coronary heart disease (including heart attack, angina)GCST9047519810.23
509Pelvic heightGCST9044891210.20
510wg lh intensity-contrast transversetemporalGCST9000382510.18
511PARK7/TNFRSF9 ratioGCST9031559910.16
512T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121)GCST9032094010.14
513ANGPTL3/TFPI ratioGCST9031327010.12
514C21orf58 levelsGCST9061838010.10
515PRTG levelsGCST9047034710.10
516Intracerebral hemorrhageGCST9001865010.09
517Childhood maltreatmentGCST9055184410.07
518Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary OperationsUKBB0000057110.05
519CCN3/PGF ratioGCST903137229.97
520Retinal arteriolar tortuosityGCST902703979.97
521Aortic aneurysm (PheCode 442.1)GCST904759939.97
522IDP dMRI TBSS ISOVF FornixGCST900044829.95
523CD40LG/TNFSF14 ratioGCST903138279.94
524CD200 levelsGCST904686069.94
525Medication use (salicylic acid and derivatives)GCST900187759.92
526Torso length to body height ratioGCST902702629.91
527COLEC12/OGN ratioGCST903141849.87
528PSAP levelsGCST904265869.86
529CD69/CDKN2D ratioGCST903138669.83
530DPP6/SEZ6L ratioGCST903145449.82
531PON1 levelsGCST904702859.82
532AGRN/HSPG2 ratioGCST903132019.82
533T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41)GCST903208609.81
534Spinal stenosis of lumbar region (PheCode 720.1)GCST904762349.79
535T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47)GCST903208669.75
536Takes medication for coronary artery/ coronary heart disease?GCST904751999.73
537Skin yellow/blue componentGCST903202599.71
538HJV levelsGCST904694559.71
539CHRDL1/SMOC2 ratioGCST903140629.70
540DTI autoptx L3 str r tractGCST903852179.66
541End-diastolic bi-ventricular shape (principal component 1)GCST904484809.65
542HSPG2 levelsGCST901793929.65
543FNDC1 levelsGCST904692569.63
544aparc-a2009s lh volume G-cuneusGCST900029359.62
545Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levelsGCST900603039.62
546Isoleucine levels (UKB data field 23465)GCST902695629.61
547BTN2A1/SMOC2 ratioGCST903135499.61
548Body size (confirmatory factor analysis Factor 21)GCST903093559.61
549FAM3B/FGF19 ratioGCST903147769.60
550CX3CL1 levelsGCST904689219.58
551VIT levelsGCST904710419.57
552Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditionsUKBB000008979.56
553Operative procedures - Haemorrhoidectomy | Summary OperationsUKBB000005809.55
554Operative procedures - Palmar fasciectomy | Summary OperationsUKBB000005869.55
555NPY/SMOC1 ratioGCST903155519.55
556CCL14 levelsGCST904685669.55
557aparc-DKTatlas rh area parstriangularisGCST900032839.54
558Gestational age at birth (child effect)GCST902684219.53
559Shoulder width to body height ratioGCST902702619.52
560Systolic blood pressureGCST903016979.52
561Inguinal hernia, bilateralFING000006829.52
562Intrahepatic cholestasis of pregnancyGCST904541999.52
563Dry age-related macular degeneration (includes geographic atrophy)FING000004809.46
564aparc-pial rh area parstriangularisGCST900031939.46
565FAP/LRRN1 ratioGCST903147839.43
566PTPRZ1 levelsGCST904703889.43
567Bioavailable testosterone levelsGCST900121049.43
568Comparative height size at age 10 | Early life factorsUKBB000001439.42
569Height (baseline)GCST905658439.41
570CD74/LILRB4 ratioGCST903138949.41
571TNFRSF11B levelsGCST902431589.40
572Diverticulosis and diverticulitis | digestiveUKBB000001919.39
573Unstable angina pectorisFING000014059.38
574Diverticulosis | digestiveUKBB000001909.38
575aparc-Desikan rh volume parstriangularisGCST900028209.36
576Low hand grip strength (60 years and older) (EWGSOP)GCST900075279.36
577Non-cancer illness code, self-reported - angina | Medical conditionsUKBB000005059.36
578SPARCL1 levelsGCST904707179.36
579GFRAL levelsGCST904693319.36
580ANGPTL7 levelsGCST904683069.35
581Free cholesterol in HDL (UKB data field 23422)GCST902695199.31
582BA-exvivo lh thickness BA2GCST900035149.31
583GlaucomaGCST900186329.30
584CCN3 levelsGCST904685899.27
585SnoringGCST0097619.26
586Coronary revascularization (ANGIO or CABG)FING000003609.26
587PECAM1/SOD2 ratioGCST903156479.25
588aparc-DKTatlas lh area cuneusGCST900032379.24
589BCL2 levelsGCST904684339.23
590Ischemic heart disease (PheCode 411)GCST904759299.23
591DBH levelsGCST904689489.22
592CCDC80/CHRDL1 ratioGCST903136709.22
593Phospholipids to total lipids ratio in large VLDLGCST900928779.21
594BA-exvivo rh volume BA3aGCST900028519.20
595ITGAM/ITGAV ratioGCST903152099.20
596APOM levelsGCST904683429.20
597TPM2 levelsGCST902431229.20
598aparc-a2009s lh thickness G-cuneusGCST900036139.20
599Spontaneous coronary artery dissectionGCST902458789.18
600Humerus length to body height ratioGCST902702599.16
601Indolelactate levelsGCST902435079.16
602CD244/FCRL6 ratioGCST903137659.16
603IDP dMRI TBSS L2 FornixGCST900041289.14
604T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 63)GCST903208829.13
605Height (standard GWA)GCST902672849.11
606Fracture of lower limb | injuries & poisoningsUKBB000002559.11
607Osteoporosis NOS | musculoskeletalUKBB000005999.10
608CKAP2 levelsGCST902408669.09
609ITGAV levelsGCST904696399.08
610Volume of right accessory basal nucleusGCST904749079.08
611Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605539.08
612DTI TBSS L1 FornixGCST903844339.07
613T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58)GCST903206219.06
614aparc-DKTatlas lh thickness cuneusGCST900035439.05
615DLK1/PIK3IP1 ratioGCST903144929.04
616Osteoporosis | musculoskeletalUKBB000005989.04
617ADGRE2/CD58 ratioGCST903131759.01
618Heart rate variability traits (SDNN)GCST0047349.01
619TNN levelsGCST904709279.00
620AnginaGCST904681098.96
621Trunk fat percentage | Impedance measuresUKBB000008648.96
622AHCY/HSPA1A ratioGCST903132118.95
623T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68)GCST903206318.94
624ADAMTSL2 levelsGCST904682288.91
625Osteopenia or other disorder of bone and cartilage (PheCode 743.9)GCST904762618.89
626Coronary artery bypass graftingFING000003588.88
627Synovitis and tenosynovitis (PheCode 727.1)GCST904762428.88
628T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122)GCST903209418.87
629DKKL1 levelsGCST904690008.86
630T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75)GCST903208948.86
631CD164/PARK7 ratioGCST903137438.86
632Bioavailable testosterone levelsGCST900121028.84
633CD109 levelsGCST904685978.84
634wg lh intensity-contrast middletemporalGCST900038068.83
635T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64)GCST903208838.82
636CCL22/TIMP3 ratioGCST903136938.81
637Varicose veins of lower extremity (PheCode 454.1)GCST904760138.79
638NCS1/NPY ratioGCST903155278.79
639CX3CL1/LAYN ratioGCST903143258.79
640Illnesses of mother - None of the above (group 1) | Family historyUKBB000003498.78
641NOTCH3 levelsGCST904700678.77
642Aspartate aminotransferase | Blood biochemistryUKBB000000528.76
643BA-exvivo lh volume BA3aGCST900028378.76
644Total thigh muscle volume z-scoreGCST902673568.72
645SELE levelsGCST904705668.70
646IDP dMRI ProbtrackX L2 unc rGCST900042998.69
647LGALS3 levelsGCST901793038.68
648Vascular/heart problems diagnosed by doctor - Angina | Medical conditionsUKBB000008968.66
649AXL levelsGCST904684068.66
650PODXL levelsGCST904702808.66
651Coronary atherosclerosis (PheCode 411.4)GCST904759368.66
652IDP dMRI TBSS L1 Superior fronto-occipital fasciculus RGCST900041178.66
653Diaphragmatic hernia | digestiveUKBB000001718.65
654CD70 levelsGCST904686458.64
655X-12411 levelsGCST902004928.63
656PTPRN2/RTBDN ratioGCST903157548.63
657rfMRI amplitudes (ICA100 node 27)GCST900046158.62
658Thoracic aortic aneurysmFING000013578.62
659T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 32)GCST903205958.62
660IDP dMRI ProbtrackX OD str rGCST900044748.61
661CIAPIN1/SNX9 ratioGCST903140688.61
662EPCAM levelsGCST904691268.60
663Deforming dorsopathiesFING000003858.59
664C3 levelsGCST904684988.59
665SERPINA3 levelsGCST904705838.55
666ALB levelsGCST904751038.53
667Triglycerides to phosphoglycerides ratio (UKB data field 23435)GCST902695328.53
668IL13RA1 levelsGCST904695528.52
669CAPG levelsGCST904685378.51
670PDGFB/SPARC ratioGCST903156288.50
671AIFM1/PLXNA4 ratioGCST903132208.47
672VSNL1 levelsGCST904710548.47
673Osteomyelitis, periostitis, and other infections involving bone (PheCode 710)GCST904762208.46
674CLK2 levelsGCST902409758.45
675Benign lipomatous neoplasm of skin and subcutaneous tissue of trunkFING000001508.44
676MATN2/SCARA5 ratioGCST903153888.43
677Disorders of breastFING000004378.43
678Retinal arteriolar widthGCST902703988.41
679Cataract | sense organsUKBB000001208.41
680DTI autoptx L3 unc l tractGCST903852188.39
681aparc-a2009s lh area S-subparietalGCST900033678.39
682IDP dMRI ProbtrackX MD cgc rGCST900042248.38
683Cryptic phenotype that captures Alport syndrome severityGCST901018288.38
684PRELP levelsGCST904703218.35
685T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46)GCST903206098.35
686ICD10 C53: Malignant neoplasm of cervix uteriGCST904542028.35
687Fracture of lower leg, including ankleFING000005558.34
688Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levelsGCST900602778.33
689Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levelsGCST900603268.33
690aparc-a2009s lh volume G-precentralGCST900029538.29
691wg lh intensity-contrast superiortemporalGCST900038218.28
692Major coronary heart disease eventFING000007468.28
693Hand grip strength (left) | Hand grip strengthUKBB000003008.27
694Volume of right lateral nucleusGCST904750348.25
695PTX3 levelsGCST904703928.25
696BA-exvivo rh volume BA4pGCST900028548.25
697Sleep apnea (MTAG) (adjusted for BMI)GCST902673648.23
698AMIGO2 levelsGCST904682928.23
699MXRA8 levelsGCST904699688.23
700Valvular heart disease excluding rheumatic feverFING000014148.23
701ITGB1 levelsGCST904696438.22
702IGF1 levelsGCST904680788.22
703HAMP levelsGCST904516838.21
704IDP dMRI TBSS L3 Sagittal stratum LGCST900042028.20
705FGF19/SCG2 ratioGCST903148098.20
706aparc-Desikan lh volume cuneusGCST900027728.20
707Benign lipomatous neoplasmFING000001468.20
708MYOC/NOTCH3 ratioGCST903155078.19
709ISLR2 levelsGCST904696298.19
710aseg global volume EstimatedTotalIntraCranialGCST900025978.19
711Female infertility, associated with anovulationFING000005378.18
712Operative procedures - Angiocardiography of left side of heart NEC | Summary OperationsUKBB000005728.17
713GPA33 levelsGCST904693858.16
714Heart attackGCST904681328.15
715IDP dMRI ProbtrackX MD ilf lGCST900042338.14
716Left-hemisphere salience/ventral attention network to right-hemisphere salience/ventral attention network white-matter structural connectivityGCST903027158.12
717O-sulfo-l-tyrosine levelsGCST902436238.12
718Volume of right cortico-amygdaloid transition areaGCST904749138.11
719Operation code - wisdom teeth surgery | OperationsUKBB000005698.11
720BLMH/PEAR1 ratioGCST903135198.11
721IDP dMRI ProbtrackX L2 cst rGCST900042828.10
722SCARF2/TNFRSF21 ratioGCST903158138.09
723Polyunsaturated fatty acids to saturated fatty acids ratioGCST905021668.07
724Free cholesterol in medium HDL (UKB data field 23570)GCST902696678.06
725Myopia (PheCode 367.1)GCST904758808.03
726BCAM levelsGCST904684258.02
727MAVS/PPP1R9B ratioGCST903153938.01
728Undecenoylcarnitine (C11:1) levelsGCST902002367.98
729Nonalcoholic fatty liver diseaseGCST902750417.97
730Left ventricular end diastolic mass end diastolic volume ratioGCST902681317.96
731FUT8/VEGFC ratioGCST903148967.96
732Palmar fascial fibromatosis [Dupuytren]FING000011417.91
733Other chronic ischemic heart disease, unspecified (PheCode 411.8)GCST904759387.91
734Benign neoplasm: Adrenal glandFING000001647.89
735NPL levelsGCST904700727.89
736CLMP/TGFBR2 ratioGCST903141357.88
737Volume of left basal nucleusGCST904749467.88
738aparc-Desikan lh volume precentralGCST900027917.87
739Angina pectoris | circulatory systemUKBB000000307.86
740Forced vital capacity (FVC) | SpirometryUKBB000002547.86
741Total protein levelsGCST900187567.85
742ALKBH3 levelsGCST906190957.84
743Heart valve disorders (PheCode 395)GCST904759137.84
744Descending aorta distensibilityGCST902673867.83
745DTI TBSS L2 Posterior corona radiata LGCST903845037.78
746Angina pectoris | Ischaemic heart diseasesUKBB000000317.78
747FABP2/RBP2 ratioGCST903147577.78
748IDP dMRI ProbtrackX MD cgc lGCST900042237.76
749Total lipids in HDL (UKB data field 23426)GCST902695237.75
750Fasciitis | musculoskeletalUKBB000002397.75
751Non-cancer illness code, self-reported - heart attack/myocardial infarction | Medical conditionsUKBB000005147.74
752X-24337 levelsGCST902006297.74
753Metabolonic lactone sulfate levelsGCST902002577.73
754wg lh intensity-contrast parsorbitalisGCST900038107.72
755aparc-Desikan lh area cuneusGCST900030777.72
756FURIN/IGSF3 ratioGCST903148857.69
757N-formylanthranilic acid levelsGCST901999607.62
758ALB levelsGCST904751067.60
759BA-exvivo lh thickness BA4aGCST900035177.60
760Left hippocampal volume (tail)GCST902679517.60
761IDP dMRI ProbtrackX MD fmaGCST900042297.59
762BCL2L15 levelsGCST904684317.59
763Osteomyelitis (PheCode 710.1)GCST904762217.58
764FAP/THBS4 ratioGCST903147857.55
765IDP T1 FAST ROIs L caudateGCST900025497.53
766ITGBL1 levelsGCST904696487.51
767Total lipids in large HDL (UKB data field 23559)GCST902696567.46
768HDL cholesterol levels (UKB data field 23406)GCST902695037.45
769Levulinate 4-oxovalerate levelsGCST902435457.44
770CX3CL1 levelsGCST900120747.44
771C3 levelsGCST902810417.44
772Coronary atherosclerosis | circulatory systemUKBB000001527.44
773ADAMTSL4 levelsGCST904682297.43
774IDP dMRI ProbtrackX L3 ilf rGCST900043157.42
775Bone marrow fat fraction of lumbar vertebra 1GCST906523867.41
776Triacylglycerol (52:4) [NL-16:0] levelsGCST900251707.40
777CLMP/TNFRSF19 ratioGCST903141367.40
778ADGRE2 levelsGCST904682377.39
779aparc-DKTatlas lh volume precentralGCST900028847.38
780IDP dMRI ProbtrackX L2 ifo lGCST900042857.37
781CD300LG/CD93 ratioGCST903138007.36
782Abdominal aortic aneurysm (PheCode 442.11)GCST904759947.36
783aparc-a2009s lh thickness G-postcentralGCST900036307.36
784CFHR4 levelsGCST900190457.35
785OsteoporosisGCST904681457.35
786Urine glucuronide of C10H18O2 (12)* levels in chronic kidney diseaseGCST902651897.33
787DTI autoptx L2 str r tractGCST903851907.31
788aparc-Desikan rh area cuneusGCST900031117.30
789Noninflammatory disorders of female genital tractFING000008827.28
790FGFR2 levelsGCST904692337.28
791Right-hemisphere limbic network to caudate white-matter structural connectivityGCST903028287.27
792Triacylglycerol_46:4_[M+NH4]1+ levelsGCST900603627.26
793COL6A3 levelsGCST904688217.26
794TSPAN8 levelsGCST904709807.26
795IDP dMRI ProbtrackX L3 fmaGCST900043107.25
796Other joint disordersFING000010647.25
797Cerebrovascular disease (PheCode 433)GCST904759857.24
798IDP dMRI ProbtrackX L2 fmaGCST900042837.21
799T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 110)GCST903209297.20
800IDP dMRI ProbtrackX L2 ifo rGCST900042867.20
801Unstable angina pectorisGCST900187127.20
802Triglyceride to phosphoglyceride ratioGCST904999967.19
803NCR3 levelsGCST900881797.19
804aparc-a2009s lh thickness S-postcentralGCST900036697.18
805Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4)GCST904762437.16
806CRIP2 levelsGCST904688647.15
807IDP dMRI ProbtrackX FA unc rGCST900039517.14
808Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24)GCST903093587.13
809DTI TBSS L2 Posterior corona radiata RGCST903845027.13
810DPP6/SEZ6L2 ratioGCST903145437.13
811Eustachian tube disorders (PheCode 381.2)GCST904759047.12
812Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB000000057.11
813TINAGL1 levelsGCST904708737.11
814MFAP4 levelsGCST904698987.10
815Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARBUKBB000006627.09
816Retinal detachments and defects | sense organsUKBB000007567.09
817CCL27 levelsGCST904685797.07
818T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209207.05
819CR2 levelsGCST904688527.05
820Succinylcarnitine levelsGCST902438747.05
821MOG/RTBDN ratioGCST903154767.04
822Saturated fatty acids to total fatty acids percentageGCST905022057.03
823Acute myocardial infarction | Ischaemic heart diseasesUKBB000000117.02
824IDP dMRI TBSS L3 Superior fronto-occipital fasciculus RGCST900042137.02
825PTPRM levelsGCST904703847.02
826T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114)GCST903206777.01
827OsteoporosisGCST900861227.00
828CREG1/NAAA ratioGCST903142507.00
829red blood cell count (RBC, maximum, inv-norm transformed)GCST904763436.99
830IDP dMRI TBSS L2 Pontine crossing tractGCST900041246.99
831DLK1 levelsGCST904690036.99
832Concentration of HDL particlesGCST904974066.98
833Total lipids in very large VLDL (UKB data field 23489)GCST902695866.98
834Sulcal opening distance of the right calloso-marginal posterior fissureGCST901049466.98
835LGALS8/VWF ratioGCST903153226.98
836HPGDS/ITGAV ratioGCST903150806.95
837CLEC14A/PIK3IP1 ratioGCST903140806.94
838GAPDH levelsGCST904693026.94
839aparc-Desikan lh volume lateraloccipitalGCST900027786.93
840Diaphragmatic hernia | HerniaUKBB000001726.92
841IDP dMRI TBSS MD Cingulum cingulate gyrus RGCST900040616.92
842Left-hemisphere control network to putamen white-matter structural connectivityGCST903027546.89
843red blood cell count (RBC, mean, inv-norm transformed)GCST904763476.89
844Age-related macular degeneration (whether dry or wet)FING000000476.86
845JAM2/TGFBR2 ratioGCST903152386.85
846SNX9/STIP1 ratioGCST903158646.84
847Docosahexaenoic acid levels (UKB data field 23450)GCST902695476.83
848Inguinal herniaGCST900186486.82
849wg lh intensity-contrast banksstsGCST900037936.81
850Tetradecadienedioate (C14:2-DC) metabolite levelGCST906162756.79
851Fibromuscular dysplasiaGCST900266126.79
852Systolic blood pressure (standard GWA)GCST902673046.79
853Cholesteryl esters in HDL (UKB data field 23418)GCST902695156.79
854Diarrhoea and gastroenteritis of presumed infectious originFING000004206.78
855Phospholipids in HDL (UKB data field 23414)GCST902695116.78
856Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6)GCST904760946.78
857NAAA levelsGCST904699916.77
858IDP dMRI TBSS MD Sagittal stratum LGCST900040586.76
859Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasoundUKBB000004286.76
860PAMR1 levelsGCST904701556.76
861TFPI2 levelsGCST904708386.76
862systolic blood pressure (SBP, mean, inv-normal transformed)GCST904764036.75
863wg rh intensity-contrast entorhinalGCST900038326.74
864Triglycerides in very large VLDL (UKB data field 23494)GCST902695916.74
865IDP dMRI TBSS L2 Cingulum hippocampus LGCST900041606.73
866HSPG2/VASN ratioGCST903150946.72
867IDP dMRI TBSS ICVF Cingulum hippocampus RGCST900043636.71
868aseg rh intensity Lateral-VentricleGCST900037786.71
869CAG-177 sp003514385 abundance in stoolGCST900322596.71
870HYAL1 levelsGCST904694956.70
871wg lh intensity-contrast caudalmiddlefrontalGCST900037956.70
872aparc-a2009s rh area G-cuneusGCST900033816.69
873DTI TBSS L3 Superior corona radiata LGCST903845496.69
874CX3CL1/RGMB ratioGCST903143276.68
875ADGRE5/GAS6 ratioGCST903131796.68
876CCL8 levelsGCST904223466.67
877COL24A1 levelsGCST904688146.67
878CDH2/CDHR2 ratioGCST903139506.66
879T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 104)GCST903206676.66
880Left-hemisphere somatomotor network to thalamus white-matter structural connectivityGCST903026826.65
881Citrate levelsGCST902434426.65
882Optic cup areaGCST0041376.65
883Glaucoma | GlaucomaUKBB000002866.64
884Mean bone marrow fat fraction of lumbar vertebrae 1-5GCST906523916.64
885Retinal detachments and breaksFING000012606.62
886LEPR levelsGCST904697566.62
887DKK4/REG1A ratioGCST903144896.62
888Diseases of external earFING000004246.60
889FSTL3/SPON2 ratioGCST903148846.60
890DAB2/TBL1X ratioGCST903143686.60
891Phenylacetylcarnitine levelsGCST901999936.59
892Total concentration of lipoprotein particlesGCST905001036.59
893aparc-a2009s rh area S-collat-transv-antGCST900034206.59
894Physical function (baseline)GCST905658376.58
895Other infective otitis externaFING000010606.58
896AGRN/BTN2A1 ratioGCST903131996.58
897Volume of left whole amygdalaGCST904749886.57
898Glaucoma | sense organsUKBB000002876.57
899IDP dMRI TBSS MD Superior fronto-occipital fasciculus LGCST900040706.57
900Testosterone levelsGCST904834866.56
901Cholesteryl Esters in HDLGCST904973686.56
902aparc-a2009s lh area G-cuneusGCST900033076.55
903Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481)GCST902695786.55
904BA-exvivo rh volume BA45GCST900028576.52
905GlaucomaGCST904681296.52
906T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16)GCST903205796.52
907Concentration of very large VLDL particles (UKB data field 23488)GCST902695856.51
908aparc-Desikan lh area lingualGCST900030856.50
909PON3 levelsGCST904702876.50
910CAG-177 abundance in stoolGCST900322616.50
911aparc-DKTatlas lh area lingualGCST900032456.46
912PON2/PON3 ratioGCST903157036.46
913MB levelsGCST904698696.45
914DTI TBSS L2 Posterior thalamic radiation RGCST903845046.45
915ALB levelsGCST904751006.45
916Phospholipids in very large VLDL (UKB data field 23490)GCST902695876.44
917Hypotaurine levelsGCST902003796.44
918MCAM levelsGCST904698706.43
919Corneal opacity and other disorders of cornea (PheCode 364)GCST904758616.43
920Skin red/green componentGCST903202586.43
921DLL4 levelsGCST904690056.43
922Biological Sibling: Coronary Artery / Coronary Heart DiseaseGCST904763706.43
923Hypertrophy of breastFING000006446.41
924Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483)GCST902695806.40
925AGER levelsGCST900120546.40
926EGF/TNFSF14 ratioGCST903146156.38
927CLEC1B/MGLL ratioGCST903140976.38
928IDP dMRI ProbtrackX MO str lGCST900040236.38
929Enteritis due to Yersinia enterocoliticaFING000005056.37
930Coronary atherosclerosisFING000003596.36
931Bone marrow fat fraction of left proximal femurGCST906523926.36
932IDP dMRI TBSS MO FornixGCST900039576.36
933Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levelsGCST902000176.36
934aparc-Desikan lh thickness precentralGCST900034686.36
935Free cholesterol to total lipids in very large HDL percentage (UKB data field 23632)GCST902697296.35
936CD99/MMP3 ratioGCST903139286.35
937aparc-a2009s lh volume G-cingul-Post-ventralGCST900029346.35
938DNA methylation PhenoAge accelerationGCST900142926.34
939BMPER levelsGCST904684556.33
940ROBO1/SPON1 ratioGCST903157836.33
941aparc-DKTatlas lh volume lateraloccipitalGCST900028716.31
942Early age-related macular degenerationGCST0107236.31
943aparc-DKTatlas lh thickness precentralGCST900035626.31
944IDP dMRI TBSS MD Corticospinal tract RGCST900040336.30
945SLC39A5 levelsGCST904706616.30
946Free cholesterol to total lipids in medium HDL percentage (UKB data field 23642)GCST902697396.30
947IDP dMRI ProbtrackX FA ifo rGCST900039386.30
948Unspecified osteomyelitis (PheCode 710.19)GCST904762246.30
949Biological Sibling: Alzheimer's / Other DementiaGCST904763756.29
950IDP dMRI TBSS L2 Cingulum hippocampus RGCST900041596.29
951FUT3 or FUT5 levelsGCST904692806.29
952Phospholipid levels in large HDLGCST900928526.28
953CTSF/SMPDL3A ratioGCST903143166.27
954aseg global volume 4th-VentricleGCST900026006.27
955Total Alkenylphosphatidylcholine levelsGCST900258356.25
956INHBC levelsGCST904696156.25
957Follicular cysts of skin and subcutaneous tissueFING000005476.22
958COMP levelsGCST904688276.21
959aparc-Desikan lh volume parsopercularisGCST900027856.20
960Cataract (PheCode 366)GCST900437856.20
961Phospholipids in large VLDL (UKB data field 23497)GCST902695946.19
962Diverticular disease of intestineFING000004716.19
963DSCAM levelsGCST904690416.19
964IDP T1 FAST ROIs L front operc cortexGCST900025316.18
965IDP T1 FIRST left putamen volumeGCST900024406.18
966wg rh intensity-contrast parstriangularisGCST900038466.18
967wg lh intensity-contrast entorhinalGCST900037976.16
968Endometriosis of ovaryFING000005016.14
969Spinal stenosis (PheCode 720)GCST904762336.14
970WIF1 levelsGCST904710786.13
971T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 106)GCST903209256.13
972Osteoarthritis, localized (PheCode 740.1)GCST904762546.12
973Myocardial infarction | circulatory systemUKBB000004916.12
974IDP dMRI TBSS FA Middle cerebellar peduncleGCST900038776.11
975COL3A1 levelsGCST904688176.10
976Retinal venular tortuosityGCST902703996.09
977DNAJA2/HPCAL1 ratioGCST903145036.09
978IDP dMRI ProbtrackX MD ar lGCST900042196.09
979Diastolic blood pressureGCST903017006.09
980LAMP1 levelsGCST904697336.08
981Total testosterone levelsGCST902398206.08
982DSG4 levelsGCST904690446.07
983DTI TBSS L2 Retrolenticular part of internal capsule LGCST903844976.06
984Breast conditions, congenital or relating to hormones (PheCode 612)GCST904761626.06
985aparc-a2009s rh area S-orbital-H-ShapedGCST900034346.06
986DSG2 levelsGCST904690426.06
987Left ventricular end systole anterolateral wall thicknessGCST902785116.06
988NCAM1 levelsGCST904700036.05
989CD48 levelsGCST904256766.05
990T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 85)GCST903209046.04
991HSD11B1/SMPD1 ratioGCST903150826.03
992T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125)GCST903209446.03
993HydrocephalusFING000006286.03
994IDP dMRI ProbtrackX L3 ifo lGCST900043126.03
995Polyunsaturated fatty acids to saturated fatty acids ratioGCST905025926.02
996ACVRL1/TNFRSF9 ratioGCST903131606.02
997rfMRI connectivity ICA-features 4GCST900063426.02
998TNFRSF4/TNFRSF9 ratioGCST903159396.02
999Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484)GCST902695816.00
1000APOA1 levelsGCST902695376.00